RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 107 filers reported holding RIGEL PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $191 | -16.2% | 177,000 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $228 | -64.7% | 177,000 | -63.8% | 0.00% | 0.0% |
| Q1 2023 | $645 | +164.3% | 489,600 | +200.0% | 0.00% | 0.0% |
| Q4 2022 | $244 | -99.9% | 163,200 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $192,000 | +4.3% | 163,200 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $184,000 | -60.0% | 163,200 | +6.0% | 0.00% | -50.0% |
| Q1 2022 | $460,000 | +12.7% | 154,000 | 0.0% | 0.00% | +100.0% |
| Q4 2021 | $408,000 | -27.0% | 154,000 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $559,000 | -13.2% | 154,000 | -12.4% | 0.00% | -33.3% |
| Q3 2016 | $644,000 | +36.7% | 175,700 | -16.8% | 0.00% | +50.0% |
| Q2 2016 | $471,000 | +16.3% | 211,300 | +8.4% | 0.00% | 0.0% |
| Q1 2016 | $405,000 | -31.4% | 195,000 | 0.0% | 0.00% | -33.3% |
| Q4 2015 | $590,000 | +74.0% | 195,000 | +42.0% | 0.00% | +50.0% |
| Q3 2015 | $339,000 | -23.0% | 137,300 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $440,000 | – | 137,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 8,350,000 | $28,557,000 | 5.86% |
| Ion Asset Management Ltd. | 3,632,132 | $12,422,000 | 1.43% |
| CM Management, LLC | 500,000 | $1,710,000 | 1.27% |
| SECTOR GAMMA AS | 1,530,490 | $5,234,000 | 0.96% |
| Rhenman & Partners Asset Management AB | 1,520,000 | $5,198,000 | 0.36% |
| Rock Springs Capital Management LP | 4,742,000 | $16,218,000 | 0.35% |
| Telemetry Investments, L.L.C. | 90,000 | $308,000 | 0.35% |
| DAFNA Capital Management LLC | 275,500 | $942,000 | 0.22% |
| KELLEHER FINANCIAL ADVISORS | 100,000 | $342,000 | 0.22% |
| Virtus ETF Advisers LLC | 91,971 | $315,000 | 0.13% |